Product · Materials Science
Product · InnDex 38 · Evidence provided · High specification risk
Self-healing concrete using dormant bacteria activated by crack water ingress to precipitate calcium carbonate.
Bacterial spores (Bacillus species) are encapsulated in clay or hydrogel and mixed into fresh concrete, where they remain dormant for years. When cracks form and water penetrates, bacteria metabolise supplied nutrients (calcium lactate or urea) to produce CaCO₃ crystals that seal voids and arrest water ingress. This targets the primary durability failure mode of concrete—water-driven corrosion and deterioration—and aims to reduce maintenance and structural repair costs over building life.
Bacterial self-healing concrete encapsulates dormant Bacillus spores in the mix so that crack-induced water ingress triggers calcium carbonate precipitation, autonomously sealing voids before corrosion of reinforcement can begin — the primary durability failure mode in most concrete structures. The appeal is whole-life: eliminating or deferring crack inspection and repair cycles has a credible cost argument over a 50-year service life, and standard concrete batching integration means it is not a disruptive process change. One deployment reference is on record, but field evidence at structural scale remains limited, and the healing mechanism has meaningful environmental dependencies — it is only effective where moisture and nutrients align, cannot operate under dry conditions, and performance is highly concrete-mix-dependent, with no universal specification yet published. The nutrient depletion question is the most important open issue for structural applications: the bacteria's capacity to heal is bounded by the initial nutrient charge, and the rate at which that charge is consumed in the first crack event — or leached over time — is not robustly characterised at scale, which means the system may not deliver on its promise for the second or third crack event in long-service structures. Regulatory and code acceptance for critical structural applications is still underdeveloped. Worth tracking for infrastructure and high-exposure envelope applications where inspection access is difficult; the honest position for a specifier today is early pilot rather than standard specification.
Laboratory efficacy is well documented (peer-reviewed studies confirm healing of cracks <0.8 mm in controlled conditions). Pilot deployments exist (e.g. bridge structures in Belgium, Netherlands) but published long-term performance data are sparse. Bacterial viability over >5 years in real structures, repeatability of healing across cycles, and performance in freeze-thaw or aggressive chemical environments lack robust field evidence. Manufacturing and quality control standardization not yet established. No major commercial product at scale in North America or Asia-Pacific. Cost premium vs. conventional concrete reported but not transparently benchmarked.
#self-healing #durability #biogenic #concrete #crack-repair #maintenance-reduction